Serve, Hubert 
; Krug, Utz ; Wagner, Ruth ; Sauerland, M. Cristina ; Heinecke, Achim ; Brunnberg, Uta ; Schaich, Markus ; Ottmann, Oliver ; Duyster, Justus ; Wandt, Hannes ; Fischer, Thomas ; Giagounidis, Aristoteles ; Neubauer, Andreas ; Reichle, Albrecht ; Aulitzky, Walter ; Noppeney, Richard ; Blau, Igor ; Kunzmann, Volker ; Stuhlmann, Reingard ; Krämer, Alwin ; Kreuzer, Karl-Anton ; Brandts, Christian ; Steffen, Björn ; Thiede, Christian ; Müller-Tidow, Carsten ; Ehninger, Gerhard ; Berdel, Wolfgang E.
; Krug, Utz ; Wagner, Ruth ; Sauerland, M. Cristina ; Heinecke, Achim ; Brunnberg, Uta ; Schaich, Markus ; Ottmann, Oliver ; Duyster, Justus ; Wandt, Hannes ; Fischer, Thomas ; Giagounidis, Aristoteles ; Neubauer, Andreas ; Reichle, Albrecht ; Aulitzky, Walter ; Noppeney, Richard ; Blau, Igor ; Kunzmann, Volker ; Stuhlmann, Reingard ; Krämer, Alwin ; Kreuzer, Karl-Anton ; Brandts, Christian ; Steffen, Björn ; Thiede, Christian ; Müller-Tidow, Carsten ; Ehninger, Gerhard ; Berdel, Wolfgang E. 
Zusammenfassung
Purpose The prognosis of elderly patients with acute myeloid leukemia (AML) is still dismal even with intensive chemotherapy. In this trial, we compared the antileukemic activity of standard induction and consolidation therapy with or without the addition of the kinase inhibitor sorafenib in elderly patients with AML. Patients and Methods All patients received standard cytarabine and daunorubicin ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric